Evidence map›Paper›PMID 27977799›Full record

ArticlePloS one2016

Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats.

Yukako Shimotsuma, Miyuu Tanaka, Takeshi Izawa, Jyoji Yamate, Mitsuru Kuwamura

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yukako ShimotsumaLaboratory of Veterinary Pathology, Osaka Prefecture University, Izumisano City, Osaka, Japan.
Miyuu TanakaLaboratory of Veterinary Pathology, Osaka Prefecture University, Izumisano City, Osaka, Japan.
Takeshi IzawaLaboratory of Veterinary Pathology, Osaka Prefecture University, Izumisano City, Osaka, Japan.
Jyoji YamateLaboratory of Veterinary Pathology, Osaka Prefecture University, Izumisano City, Osaka, Japan.
Mitsuru KuwamuraLaboratory of Veterinary Pathology, Osaka Prefecture University, Izumisano City, Osaka, Japan.
Osaka Prefecture University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demyelination (dmy) rat exhibits hind limb ataxia and severe myelin breakdown in the central nervous system. The causative gene of dmy rats is the MRS2 magnesium transporter gene. Tribbles homolog 3 (Trib3) is a pseudokinase molecule that modifies certain signal pathways, and its expression is increased in response to various stresses. Here we sought to clarify the mechanism of myelin breakdown by focusing Trib3, which is remarkably up-regulated in dmy rats. The expression of Trib3 mRNA was significantly increased at 4, 5, 6, 7 and 8 weeks of age in the dmy rats, prior to the prominent myelin breakdown between 7 and 10 weeks of age. The expression level of Trib3 was increased concurrently with the progression of the clinical and pathological conditions in the dmy rats. Double immunofluorescence demonstrated that TRIB3 was mainly expressed in neurons and oligodendrocytes and localized in the Golgi apparatus. Our findings indicate that Trib3 may be associated with the pathogenic mechanism of dmy rats.

Indexed as

AnimalsDemyelinating DiseasesFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalMaleMicroarray AnalysisMyelin SheathProtein Serine-Threonine KinasesRatsRats, Mutant StrainsRats, TransgenicUp-RegulationProtein Serine-Threonine KinasesTrib3 protein, rat

Identifiers

PMID27977799
PMCPMC5158197
OpenAlexW2565744966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.